| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol binding | 1.25e-04 | 16 | 21 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.98e-03 | 279 | 21 | 3 | GO:0005096 | |
| Domain | RhoGAP | 4.44e-05 | 62 | 21 | 3 | SM00324 | |
| Domain | RhoGAP | 4.66e-05 | 63 | 21 | 3 | PF00620 | |
| Domain | RhoGAP_dom | 4.88e-05 | 64 | 21 | 3 | IPR000198 | |
| Domain | - | 4.88e-05 | 64 | 21 | 3 | 1.10.555.10 | |
| Domain | RHOGAP | 4.88e-05 | 64 | 21 | 3 | PS50238 | |
| Domain | Rho_GTPase_activation_prot | 1.26e-04 | 88 | 21 | 3 | IPR008936 | |
| Domain | RRM_1 | 1.56e-03 | 208 | 21 | 3 | PF00076 | |
| Domain | RRM | 1.76e-03 | 217 | 21 | 3 | SM00360 | |
| Domain | RRM_dom | 2.00e-03 | 227 | 21 | 3 | IPR000504 | |
| Domain | RRM | 2.08e-03 | 230 | 21 | 3 | PS50102 | |
| Domain | - | 2.46e-03 | 244 | 21 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.88e-03 | 258 | 21 | 3 | IPR012677 | |
| Domain | Kinase-like_dom | 2.19e-02 | 542 | 21 | 3 | IPR011009 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.83e-04 | 16 | 18 | 2 | MM15605 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.18e-04 | 94 | 18 | 3 | MM15598 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 7.31e-04 | 142 | 18 | 3 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 8.40e-04 | 149 | 18 | 3 | M41805 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 9.42e-04 | 155 | 18 | 3 | M41808 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.34e-03 | 175 | 18 | 3 | MM15599 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.35e-03 | 43 | 18 | 2 | M41827 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.41e-03 | 44 | 18 | 2 | MM15678 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.55e-03 | 184 | 18 | 3 | M41809 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.01e-03 | 439 | 18 | 4 | MM15595 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 2.04e-03 | 53 | 18 | 2 | M41811 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.20e-03 | 450 | 18 | 4 | M27078 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 2.20e-03 | 55 | 18 | 2 | M41815 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 2.44e-03 | 58 | 18 | 2 | MM15602 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 2.52e-03 | 59 | 18 | 2 | M41812 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 2.96e-03 | 64 | 18 | 2 | MM15601 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.43e-03 | 69 | 18 | 2 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.53e-03 | 70 | 18 | 2 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.53e-03 | 70 | 18 | 2 | MM15597 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 3.63e-03 | 71 | 18 | 2 | MM15604 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.94e-03 | 74 | 18 | 2 | M41807 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 3.94e-03 | 74 | 18 | 2 | M41814 | |
| Pubmed | Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1. | 2.08e-06 | 4 | 21 | 2 | 9548756 | |
| Pubmed | Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release. | 2.08e-06 | 4 | 21 | 2 | 19393081 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 3.38e-06 | 1155 | 21 | 7 | 20360068 | |
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 9535855 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 7.49e-05 | 1257 | 21 | 6 | 36526897 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 9.49e-05 | 148 | 21 | 3 | 32538781 | |
| Pubmed | 1.03e-04 | 25 | 21 | 2 | 12522145 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.29e-04 | 853 | 21 | 5 | 28718761 | |
| Pubmed | Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. | 1.30e-04 | 28 | 21 | 2 | 19596686 | |
| Pubmed | 1.40e-04 | 29 | 21 | 2 | 19279220 | ||
| Pubmed | 1.53e-04 | 1431 | 21 | 6 | 37142655 | ||
| Pubmed | 1.60e-04 | 31 | 21 | 2 | 12171929 | ||
| Pubmed | 1.70e-04 | 32 | 21 | 2 | 19542561 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.97e-04 | 934 | 21 | 5 | 33916271 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 2.05e-04 | 498 | 21 | 4 | 36634849 | |
| Pubmed | 2.29e-04 | 513 | 21 | 4 | 25798074 | ||
| Pubmed | 2.63e-04 | 209 | 21 | 3 | 26389662 | ||
| Pubmed | 3.54e-04 | 46 | 21 | 2 | 19928837 | ||
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 4.18e-04 | 50 | 21 | 2 | 24769233 | |
| Pubmed | 4.38e-04 | 249 | 21 | 3 | 30097533 | ||
| Pubmed | 4.59e-04 | 253 | 21 | 3 | 29911972 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 4.88e-04 | 626 | 21 | 4 | 33644029 | |
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 5.06e-04 | 55 | 21 | 2 | 23178491 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.61e-04 | 271 | 21 | 3 | 32433965 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.30e-06 | 50 | 12 | 3 | 721 | |
| GeneFamily | RNA binding motif containing | 3.28e-04 | 213 | 12 | 3 | 725 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.80e-05 | 403 | 21 | 5 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 9.63e-05 | 804 | 21 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 9.76e-05 | 806 | 21 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-06 | 170 | 21 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.44e-06 | 181 | 21 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 173 | 21 | 3 | 7e2149205e119cec4f5099c83c85d1e13470137a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.68e-05 | 178 | 21 | 3 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.81e-05 | 179 | 21 | 3 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-05 | 180 | 21 | 3 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 8.61e-05 | 185 | 21 | 3 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.61e-05 | 185 | 21 | 3 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 8.75e-05 | 186 | 21 | 3 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 8.89e-05 | 187 | 21 | 3 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-05 | 190 | 21 | 3 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 9.47e-05 | 191 | 21 | 3 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.47e-05 | 191 | 21 | 3 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.62e-05 | 192 | 21 | 3 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 9.62e-05 | 192 | 21 | 3 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.62e-05 | 192 | 21 | 3 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.62e-05 | 192 | 21 | 3 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.76e-05 | 193 | 21 | 3 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.76e-05 | 193 | 21 | 3 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.76e-05 | 193 | 21 | 3 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.91e-05 | 194 | 21 | 3 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.91e-05 | 194 | 21 | 3 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-05 | 194 | 21 | 3 | 24f9de4781666c96c4a2d04f8a444543dbd99cbe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 196 | 21 | 3 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 196 | 21 | 3 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.04e-04 | 197 | 21 | 3 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Severe-B_naive-4|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.07e-04 | 199 | 21 | 3 | e02e482cca6a00d2980e750bca6de598819aa1b2 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-04 | 200 | 21 | 3 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 21 | 3 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Neuronal-Cortical_neuron|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-04 | 34 | 21 | 2 | 6c9c477b43009cded5a2e1a1792c32c40d9309a8 | |
| Disease | body weight | 9.29e-03 | 1261 | 20 | 4 | EFO_0004338 | |
| Disease | fat body mass | 9.37e-03 | 217 | 20 | 2 | EFO_0005409 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVKAKHNLMTVEQNN | 606 | Q13523 | |
| HNLMTVEQNNGSSQK | 611 | Q13523 | |
| KDTKNVNSNTGMQTT | 46 | Q9P2B7 | |
| MTGKTQTSNVTNKND | 1 | Q86SE5 | |
| MQSNKTFNLEKQNHT | 1 | Q15233 | |
| VSHQEFSKMKQSNNE | 631 | Q8WUM4 | |
| DSVASNNKDQNSMKH | 591 | Q76FK4 | |
| QHRDKMQQSKNQSAD | 351 | Q9Y6M4 | |
| STNNQKKAQDSSLHM | 426 | Q9BQG0 | |
| LTENSKQHNITQHMK | 151 | Q9NQC8 | |
| KSQAFNMKQDHTTQR | 531 | Q6PGQ7 | |
| QKNNKDSHSLTTNIM | 96 | P02671 | |
| EMKKSVHTQVNTNTT | 261 | Q5FWF5 | |
| SHNASKTLNANNMET | 6 | Q8N103 | |
| QQEHKRKASSSGNMN | 36 | Q96RN1 | |
| VQISAHSDQNKMTNT | 376 | Q07960 | |
| SVVQNNNTSQMSHKK | 1491 | Q5T5P2 | |
| KVSHNNKVNLMTSEN | 1381 | Q9NRY4 | |
| ANKSSQASQNRHSME | 311 | Q7Z6J0 | |
| EQVQVLSSKSHQNNM | 391 | Q8WUD6 | |
| NKAAHVQQMKTVKQS | 576 | O14795 | |
| SQQAMNSGKTKSHFQ | 101 | Q8N393 | |
| TTEHLKNANQQKESM | 2296 | Q5VU43 |